Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

  • Challenge: Developing novel diagnostic strategies

Oxford researchers are using polygenic risk scores to guide clinical decision-making leading up to, and after a diagnosis of cancer. This is being achieved by developing individualised risk scores compared with general population risk and alongside other established clinical and molecular markers.